Original Source(s)
Related Content
Inside Focus A-Eye’s Inaugural Meeting
Sharon Bakalash, MD, PhD, CBA, describes how the interdisciplinary pre-ARVO forum explored ways to move AI from concept to clinic.
May 1, 2026
-
2 min
IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial
At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.
by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS
May 1, 2026
-
4 min